BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33944652)

  • 1. Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21.
    Zhu D; Shi C; Jiang Y; Zhu K; Wang X; Feng W
    Bioengineered; 2021 Dec; 12(1):1505-1516. PubMed ID: 33944652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long intergenic noncoding RNA-p21 inhibits apoptosis by decreasing PUMA expression in non-small cell lung cancer.
    Yang T; Zhang W; Wang L; Xiao C; Guo B; Gong Y; Liang X; Huang D; Li Q; Nan Y; Xiang Y; Shao J
    J Int Med Res; 2019 Jan; 47(1):481-493. PubMed ID: 30556447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-Dependent LincRNA-p21 Protects Against Proliferation and Anti-apoptosis of Vascular Smooth Muscle Cells in Atherosclerosis by Upregulating SIRT7 via MicroRNA-17-5p.
    Wang H; He F; Liang B; Jing Y; Zhang P; Liu W; Zhao H
    J Cardiovasc Transl Res; 2021 Jun; 14(3):426-440. PubMed ID: 33169349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Novel lincRNA-p21-miR-181b-PTEN Signaling Cascade in Liver Fibrosis.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Mediators Inflamm; 2016; 2016():9856538. PubMed ID: 27610008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisatracurium inhibits the proliferation, migration and invasion of breast cancer cells by regulating the expression of miR-3174.
    Yang X; Ma W
    Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):1-7. PubMed ID: 33040777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
    Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long intragenic non-coding RNA lincRNA-p21 suppresses development of human prostate cancer.
    Wang X; Ruan Y; Wang X; Zhao W; Jiang Q; Jiang C; Zhao Y; Xu Y; Sun F; Zhu Y; Xia S; Xu D
    Cell Prolif; 2017 Apr; 50(2):. PubMed ID: 27976428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LincRNA-P21 knockdown facilitates esophageal squamous cell carcinoma cell progression by upregulating cadherin 5 via YTH domain containing 1.
    Wang J; Zhu L; Zhang Q; Xia T; Yao W; Wei L
    Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1797-1805. PubMed ID: 37766459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisatracurium-induced proliferation impairment and death of colorectal cancer cells, HCT116 is mediated by p53 dependent intrinsic apoptotic pathway in vitro.
    Yabasin IB; Lu Z; Yu JC; Wen Q
    Biomed Pharmacother; 2017 Jul; 91():320-329. PubMed ID: 28463795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.
    Abo Elwafa R; Abd Elrahman A; Ghallab O
    Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
    Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development.
    Zhou L; Tian Y; Guo F; Yu B; Li J; Xu H; Su Z
    Cancer Immunol Immunother; 2020 May; 69(5):835-846. PubMed ID: 32062693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LincRNA-p21 acts as a mediator of ING1b-induced apoptosis.
    Tran UM; Rajarajacholan U; Soh J; Kim TS; Thalappilly S; Sensen CW; Riabowol K
    Cell Death Dis; 2015 Mar; 6(3):e1668. PubMed ID: 25741593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisatracurium regulates the CXCR4/let-7a-5p axis to inhibit colorectal cancer progression by suppressing TGF-β/SMAD2/3 signalling.
    Xia YZ; Shan GF; Yang H; Zha J; Wang L; Chen JM; Zhang XS
    Chem Biol Interact; 2021 Apr; 339():109424. PubMed ID: 33617803
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhang Y; Miao Y; Shang M; Liu M; Liu R; Pan E; Pu Y; Yin L
    Cancer Manag Res; 2019; 11():6201-6214. PubMed ID: 31308755
    [No Abstract]   [Full Text] [Related]  

  • 17. Cisatracurium besilate enhances the TRAIL-induced apoptosis of gastric cancer cells via p53 signaling.
    Zhou Q; Yuan J; Liu Y; Wu Y
    Bioengineered; 2021 Dec; 12(2):11213-11224. PubMed ID: 34845969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes.
    Hall JR; Messenger ZJ; Tam HW; Phillips SL; Recio L; Smart RC
    Cell Death Dis; 2015 Mar; 6(3):e1700. PubMed ID: 25789975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity.
    Wu G; Cai J; Han Y; Chen J; Huang ZP; Chen C; Cai Y; Huang H; Yang Y; Liu Y; Xu Z; He D; Zhang X; Hu X; Pinello L; Zhong D; He F; Yuan GC; Wang DZ; Zeng C
    Circulation; 2014 Oct; 130(17):1452-1465. PubMed ID: 25156994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.
    Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B
    Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.